Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Genomic insights of reduced teicoplanin susceptible community acquired methicillin resistant Staphylococcus aureus MRSA: Case of necrotizing fasciitis.

Bakthavatchalam YD, Ramaswamy B, Janakiraman R, Steve RJ, Veeraraghavan B.

J Glob Antimicrob Resist. 2018 May 15. pii: S2213-7165(18)30090-0. doi: 10.1016/j.jgar.2018.05.006. [Epub ahead of print]

PMID:
29775787
2.

Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation.

Ahirwar DK, Nasser MW, Ouseph MM, Elbaz M, Cuitiño MC, Kladney RD, Varikuti S, Kaul K, Satoskar AR, Ramaswamy B, Zhang X, Ostrowski MC, Leone G, Ganju RK.

Oncogene. 2018 May 3. doi: 10.1038/s41388-018-0263-7. [Epub ahead of print]

PMID:
29720724
3.

Nasal septal schwannoma: a rare sinonasal tumour with certain peculiarities.

Devaraja K, Nayak DR, Ramaswamy B, Rao P.

BMJ Case Rep. 2018 Apr 18;2018. pii: bcr-2017-223850. doi: 10.1136/bcr-2017-223850.

PMID:
29669769
4.

Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102.

Kornblum N, Zhao F, Manola J, Klein P, Ramaswamy B, Brufsky A, Stella PJ, Burnette B, Telli M, Makower DF, Cheema P, Truica CI, Wolff AC, Soori GS, Haley B, Wassenaar TR, Goldstein LJ, Miller KD, Sparano JA.

J Clin Oncol. 2018 Apr 17:JCO2017769331. doi: 10.1200/JCO.2017.76.9331. [Epub ahead of print]

PMID:
29664714
5.

Targeting Tissue Factor for Immunotherapy of Triple-Negative Breast Cancer Using a Second-Generation ICON.

Hu Z, Shen R, Campbell A, McMichael E, Yu L, Ramaswamy B, London CA, Xu T, Carson WE 3rd.

Cancer Immunol Res. 2018 Apr 5. doi: 10.1158/2326-6066.CIR-17-0343. [Epub ahead of print]

PMID:
29622581
6.

Rhinofacialentomophthoromycosis.

Menon S, Pujary K, Kudva R, Ramaswamy B.

BMJ Case Rep. 2018 Mar 22;2018. pii: bcr-2017-223608. doi: 10.1136/bcr-2017-223608.

PMID:
29572369
7.

Anti-microRNA-222 (anti-miR-222) and -181B suppresses growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal.

Lu Y, Roy S, Nuovo G, Ramaswamy B, Miller T, Shapiro C, Jacob ST, Majumder S.

J Biol Chem. 2018 Mar 9;293(10):3588. doi: 10.1074/jbc.W118.002430. No abstract available.

8.

Erector spinae plane block may aid weaning from mechanical ventilation in patients with multiple rib fractures: Case report of two cases.

Nandhakumar A, Nair A, Bharath VK, Kalingarayar S, Ramaswamy BP, Dhatchinamoorthi D.

Indian J Anaesth. 2018 Feb;62(2):139-141. doi: 10.4103/ija.IJA_599_17.

9.

A hedgehog pathway-dependent gene signature is associated with poor clinical outcomes in Luminal A breast cancer.

Rudolph M, Sizemore ST, Lu Y, Teng KY, Basree MM, Reinbolt R, Timmers CD, Leone G, Ostrowski MC, Majumder S, Ramaswamy B.

Breast Cancer Res Treat. 2018 Jun;169(3):457-467. doi: 10.1007/s10549-018-4718-x. Epub 2018 Feb 20.

PMID:
29464534
10.

Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain.

Lustberg MB, Orchard TS, Reinbolt R, Andridge R, Pan X, Belury M, Cole R, Logan A, Layman R, Ramaswamy B, Wesolowski R, Berger M, Patterson E, Loprinzi C, Shapiro CL, Yee L.

Breast Cancer Res Treat. 2018 Feb;167(3):709-718. doi: 10.1007/s10549-017-4559-z. Epub 2017 Nov 3.

PMID:
29101597
11.

Middle Ear Histopathology Following Magnetic Delivery to the Cochlea of Prednisolone-loaded Iron Oxide Nanoparticles in Rats.

Lafond JF, Shimoji M, Ramaswamy B, Shukoor MI, Malik P, Shapiro B, Depireux DA.

Toxicol Pathol. 2018 Jan;46(1):101-106. doi: 10.1177/0192623317732028. Epub 2017 Oct 9.

PMID:
28992726
12.

Magnetic Nanoparticle Mediated Steroid Delivery Mitigates Cisplatin Induced Hearing Loss.

Ramaswamy B, Roy S, Apolo AB, Shapiro B, Depireux DA.

Front Cell Neurosci. 2017 Sep 13;11:268. doi: 10.3389/fncel.2017.00268. eCollection 2017.

13.

Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: a New York Cancer Consortium trial.

Adelson K, Ramaswamy B, Sparano JA, Christos PJ, Wright JJ, Raptis G, Han G, Villalona-Calero M, Ma CX, Hershman D, Baar J, Klein P, Cigler T, Budd GT, Novik Y, Tan AR, Tannenbaum S, Goel A, Levine E, Shapiro CL, Andreopoulou E, Naughton M, Kalinsky K, Waxman S, Germain D.

NPJ Breast Cancer. 2016 Dec 14;2:16037. doi: 10.1038/npjbcancer.2016.37. eCollection 2016.

14.

Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer.

Wesolowski R, Duggan MC, Stiff A, Markowitz J, Trikha P, Levine KM, Schoenfield L, Abdel-Rasoul M, Layman R, Ramaswamy B, Macrae ER, Lustberg MB, Reinbolt RE, Mrozek E, Byrd JC, Caligiuri MA, Mace TA, Carson WE 3rd.

Cancer Immunol Immunother. 2017 Nov;66(11):1437-1447. doi: 10.1007/s00262-017-2038-3. Epub 2017 Jul 7.

PMID:
28688082
15.

Discovery of Stromal Regulatory Networks that Suppress Ras-Sensitized Epithelial Cell Proliferation.

Liu H, Dowdle JA, Khurshid S, Sullivan NJ, Bertos N, Rambani K, Mair M, Daniel P, Wheeler E, Tang X, Toth K, Lause M, Harrigan ME, Eiring K, Sullivan C, Sullivan MJ, Chang SW, Srivastava S, Conway JS, Kladney R, McElroy J, Bae S, Lu Y, Tofigh A, Saleh SMI, Fernandez SA, Parvin JD, Coppola V, Macrae ER, Majumder S, Shapiro CL, Yee LD, Ramaswamy B, Hallett M, Ostrowski MC, Park M, Chamberlin HM, Leone G.

Dev Cell. 2017 May 22;41(4):392-407.e6. doi: 10.1016/j.devcel.2017.04.024.

PMID:
28535374
16.

Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients.

Monfort SM, Pan X, Patrick R, Ramaswamy B, Wesolowski R, Naughton MJ, Loprinzi CL, Chaudhari AMW, Lustberg MB.

Breast Cancer Res Treat. 2017 Jul;164(1):69-77. doi: 10.1007/s10549-017-4230-8. Epub 2017 Apr 3.

PMID:
28374323
17.

Ecotoxicological assessment of cobalt using Hydra model: ROS, oxidative stress, DNA damage, cell cycle arrest, and apoptosis as mechanisms of toxicity.

Zeeshan M, Murugadas A, Ghaskadbi S, Ramaswamy BR, Akbarsha MA.

Environ Pollut. 2017 May;224:54-69. doi: 10.1016/j.envpol.2016.12.042. Epub 2017 Feb 17.

PMID:
28222982
18.

Evaluating spatial distribution and seasonal variation of phthalates using passive air sampling in southern India.

Sampath S, Selvaraj KK, Shanmugam G, Krishnamoorthy V, Chakraborty P, Ramaswamy BR.

Environ Pollut. 2017 Feb;221:407-417. doi: 10.1016/j.envpol.2016.12.003. Epub 2016 Dec 12.

PMID:
27979682
19.

Seaweeds: A resource for marine bionanotechnology.

Vijayan SR, Santhiyagu P, Ramasamy R, Arivalagan P, Kumar G, Ethiraj K, Ramaswamy BR.

Enzyme Microb Technol. 2016 Dec;95:45-57. doi: 10.1016/j.enzmictec.2016.06.009. Epub 2016 Jun 15. Review.

PMID:
27866626
20.

A Short Term Subjective and Objective Analysis of Modified Endoscopic Lothrop's Procedure and Its Functional Outcome: Our Experience.

Nayak DR, Pai K, Nair S, Ramaswamy B, Sabhahit H.

Indian J Otolaryngol Head Neck Surg. 2016 Dec;68(4):481-486. Epub 2016 May 28.

21.

Benign Lymphoepithelial Cyst of the Parotid in HIV Negative Patient.

Pillai S, Agarwal AC, Mangalore AB, Ramaswamy B, Shetty S.

J Clin Diagn Res. 2016 Apr;10(4):MD05-6. doi: 10.7860/JCDR/2016/17915.7609. Epub 2016 Apr 1.

22.

Good-quality social care for people with Parkinson's disease: a qualitative study.

Tod AM, Kennedy F, Stocks AJ, McDonnell A, Ramaswamy B, Wood B, Whitfield M.

BMJ Open. 2016 Feb 16;6(2):e006813. doi: 10.1136/bmjopen-2014-006813.

23.

A Comprehensive Program for the Enhancement of Accrual to Clinical Trials.

Porter M, Ramaswamy B, Beisler K, Neki P, Single N, Thomas J, Hofacker J, Caligiuri M, Carson WE 3rd.

Ann Surg Oncol. 2016 Jul;23(7):2146-52. doi: 10.1245/s10434-016-5091-9. Epub 2016 Jan 20.

PMID:
26790668
24.

Mobile health application for remote oral cancer surveillance.

Birur PN, Sunny SP, Jena S, Kandasarma U, Raghavan S, Ramaswamy B, Shanmugam SP, Patrick S, Kuriakose R, Mallaiah J, Suresh A, Chigurupati R, Desai R, Kuriakose MA.

J Am Dent Assoc. 2015 Dec;146(12):886-94. doi: 10.1016/j.adaj.2015.05.020.

PMID:
26610833
25.

Ganglioneuroblastoma of Skull Base.

Ramaswamy B, Bhandarkar AM, Menon SS, Agarwal AC, Nair SS.

J Clin Diagn Res. 2015 Aug;9(8):MD01-3. doi: 10.7860/JCDR/2015/14135.6334. Epub 2015 Aug 1.

26.

Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer.

Mangini NS, Wesolowski R, Ramaswamy B, Lustberg MB, Berger MJ.

Ann Pharmacother. 2015 Nov;49(11):1252-60. doi: 10.1177/1060028015602273. Epub 2015 Aug 31. Review.

PMID:
26324355
27.

Recurrent angioleiomyoma of the middle turbinate.

Bhandarkar AM, Ramaswamy B, Jaiprakash P, Chidambaranathan N.

BMJ Case Rep. 2015 Aug 3;2015. pii: bcr2015210686. doi: 10.1136/bcr-2015-210686.

28.

QUANTIFYING THE MOTION OF MAGNETIC PARTICLES IN EXCISED TISSUE: EFFECT OF PARTICLE PROPERTIES AND APPLIED MAGNETIC FIELD.

Kulkarni S, Ramaswamy B, Horton E, Gangapuram S, Nacev A, Depireux D, Shimoji M, Shapiro B.

J Magn Magn Mater. 2015 Nov 1;393:243-252.

29.

Movement of magnetic nanoparticles in brain tissue: mechanisms and impact on normal neuronal function.

Ramaswamy B, Kulkarni SD, Villar PS, Smith RS, Eberly C, Araneda RC, Depireux DA, Shapiro B.

Nanomedicine. 2015 Oct;11(7):1821-9. doi: 10.1016/j.nano.2015.06.003. Epub 2015 Jun 24.

30.

Sclerosing lipogranuloma of the eyelid: unusual complication following nasal packing in endoscopic sinus surgery.

Ramaswamy B, Singh R, Manusrut M, Hazarika M.

BMJ Case Rep. 2015 Mar 6;2015. pii: bcr2014208093. doi: 10.1136/bcr-2014-208093.

31.

Neoadjuvant dual HER2-targeted therapy with lapatinib and trastuzumab improves pathologic complete response in patients with early stage HER2-positive breast cancer: a meta-analysis of randomized prospective clinical trials.

Hicks M, Macrae ER, Abdel-Rasoul M, Layman R, Friedman S, Querry J, Lustberg M, Ramaswamy B, Mrozek E, Shapiro C, Wesolowski R.

Oncologist. 2015 Apr;20(4):337-43. doi: 10.1634/theoncologist.2014-0334. Epub 2015 Mar 2.

32.

Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction.

Berger MJ, Vargo C, Vincent M, Shaver K, Phillips G, Layman R, Macrae E, Mrozek E, Ramaswamy B, Wesolowski R, Shapiro CL, Lustberg MB.

Support Care Cancer. 2015 Jul;23(7):2019-24. doi: 10.1007/s00520-014-2556-x. Epub 2014 Dec 18.

33.

Mechanisms and therapeutic advances in the management of endocrine-resistant breast cancer.

Zhao M, Ramaswamy B.

World J Clin Oncol. 2014 Aug 10;5(3):248-62. doi: 10.5306/wjco.v5.i3.248. Review.

34.

Phthalate esters in water and sediments of the Kaveri River, India: environmental levels and ecotoxicological evaluations.

Selvaraj KK, Sundaramoorthy G, Ravichandran PK, Girijan GK, Sampath S, Ramaswamy BR.

Environ Geochem Health. 2015 Feb;37(1):83-96. doi: 10.1007/s10653-014-9632-5. Epub 2014 Jul 24.

PMID:
25056812
35.

Antidepressant-induced Burning Mouth Syndrome: A Unique Case.

Raghavan SA, Puttaswamiah RN, Birur PN, Ramaswamy B, Sunny SP.

Korean J Pain. 2014 Jul;27(3):294-6. doi: 10.3344/kjp.2014.27.3.294. Epub 2014 Jun 30.

36.

A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer.

Zhao M, Pan X, Layman R, Lustberg MB, Mrozek E, Macrae ER, Wesolowski R, Carothers S, Puhalla S, Shapiro CL, Ramaswamy B.

Invest New Drugs. 2014 Dec;32(6):1285-94. doi: 10.1007/s10637-014-0122-5. Epub 2014 Jun 5.

37.

Amelanotic malignant melanoma of the cervical oesophagus.

Ramaswamy B, Bhandarkar AM, Venkitachalam S, Trivedi S.

BMJ Case Rep. 2014 Apr 12;2014. pii: bcr2014204182. doi: 10.1136/bcr-2014-204182.

38.

Phase II trial of neoadjuvant weekly nanoparticle albumin-bound paclitaxel, carboplatin, and biweekly bevacizumab therapy in women with clinical stage II or III HER2-negative breast cancer.

Mrózek E, Layman R, Ramaswamy B, Lustberg M, Vecchione A, Knopp MV, Shapiro CL.

Clin Breast Cancer. 2014 Aug;14(4):228-34. doi: 10.1016/j.clbc.2014.02.005. Epub 2014 Feb 20.

39.

Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.

Lustberg MB, Balasubramanian P, Miller B, Garcia-Villa A, Deighan C, Wu Y, Carothers S, Berger M, Ramaswamy B, Macrae ER, Wesolowski R, Layman RM, Mrozek E, Pan X, Summers TA, Shapiro CL, Chalmers JJ.

Breast Cancer Res. 2014 Mar 6;16(2):R23. doi: 10.1186/bcr3622.

40.

Juvenile aggressive cemento-ossifying fibroma of the sphenoid sinus with proptosis: a surgical dilemma.

Singh R, Ramaswamy B, Hazarika M.

BMJ Case Rep. 2013 Nov 27;2013. pii: bcr2013201578. doi: 10.1136/bcr-2013-201578.

41.

Paraben resistance in bacteria from sewage treatment plant effluents in India.

Selvaraj KK, Sivakumar S, Sampath S, Shanmugam G, Sundaresan U, Ramaswamy BR.

Water Sci Technol. 2013;68(9):2067-73. doi: 10.2166/wst.2013.447.

PMID:
24225110
42.

GC-MS determination of bisphenol A and alkylphenol ethoxylates in river water from India and their ecotoxicological risk assessment.

Selvaraj KK, Shanmugam G, Sampath S, Larsson DG, Ramaswamy BR.

Ecotoxicol Environ Saf. 2014 Jan;99:13-20. doi: 10.1016/j.ecoenv.2013.09.006. Epub 2013 Nov 1.

PMID:
24183982
43.

Non-steroidal anti-inflammatory drugs in Indian rivers.

Shanmugam G, Sampath S, Selvaraj KK, Larsson DG, Ramaswamy BR.

Environ Sci Pollut Res Int. 2014 Jan;21(2):921-31. doi: 10.1007/s11356-013-1957-6. Epub 2013 Jul 7.

PMID:
23832803
44.

Pilot study on the efficacy of an ondansetron- versus palonosetron-containing antiemetic regimen prior to highly emetogenic chemotherapy.

Wenzell CM, Berger MJ, Blazer MA, Crawford BS, Griffith NL, Wesolowski R, Lustberg MB, Phillips GS, Ramaswamy B, Mrozek E, Flynn JM, Shapiro CL, Layman RM.

Support Care Cancer. 2013 Oct;21(10):2845-51. doi: 10.1007/s00520-013-1865-9. Epub 2013 Jun 8.

45.

Endoscopic approach to middle turbinate squeeze syndrome.

Nayak DR, Ramaswamy B.

Indian J Otolaryngol Head Neck Surg. 2012 Jun;64(2):167-71. doi: 10.1007/s12070-011-0245-3. Epub 2011 Apr 12.

46.

Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review.

Poi MJ, Berger M, Lustberg M, Layman R, Shapiro CL, Ramaswamy B, Mrozek E, Olson E, Wesolowski R.

Support Care Cancer. 2013 Oct;21(10):2679-86. doi: 10.1007/s00520-013-1842-3. Epub 2013 May 19.

47.

Severe and prolonged lymphopenia observed in patients treated with bendamustine and erlotinib for metastatic triple negative breast cancer.

Layman RM, Ruppert AS, Lynn M, Mrozek E, Ramaswamy B, Lustberg MB, Wesolowski R, Ottman S, Carothers S, Bingman A, Reinbolt R, Kraut EH, Shapiro CL.

Cancer Chemother Pharmacol. 2013 May;71(5):1183-90. doi: 10.1007/s00280-013-2112-2. Epub 2013 Feb 21.

48.

Assessment of γ-H2AX levels in circulating tumor cells from patients receiving chemotherapy.

Garcia-Villa A, Balasubramanian P, Miller BL, Lustberg MB, Ramaswamy B, Chalmers JJ.

Front Oncol. 2012 Oct 25;2:128. doi: 10.3389/fonc.2012.00128. eCollection 2012.

49.

Perchlorate contamination of groundwater from fireworks manufacturing area in South India.

Isobe T, Ogawa SP, Sugimoto R, Ramu K, Sudaryanto A, Malarvannan G, Devanathan G, Ramaswamy BR, Munuswamy N, Ganesh DS, Sivakumar J, Sethuraman A, Parthasarathy V, Subramanian A, Field J, Tanabe S.

Environ Monit Assess. 2013 Jul;185(7):5627-37. doi: 10.1007/s10661-012-2972-7. Epub 2012 Oct 30.

PMID:
23108714
50.

Assessment of FANCD2 nuclear foci formation in paraffin-embedded tumors: a potential patient-enrichment strategy for treatment with DNA interstrand crosslinking agents.

Duan W, Gao L, Zhao W, Leon M, Sadee W, Webb A, Resnick K, Wu X, Ramaswamy B, Cohn DE, Shapiro C, Andreassen PR, Otterson GA, Villalona-Calero MA.

Transl Res. 2013 Mar;161(3):156-64. doi: 10.1016/j.trsl.2012.09.003. Epub 2012 Oct 11.

Supplemental Content

Loading ...
Support Center